YXZXA2016002/Jiangsu Provincial Key Medical Center[Grants and Funding] - Search Results

Year	Number of Results
2018	1
2019	3
2020	4
2021	3
2022	4
2023	3
2024	4

1

Epstein-Barr virus and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation in patients with non-Hodgkin lymphoma: the prevalence and impacts on outcomes : EBV and CMV reactivation post allo-HCT in NHL.

Ding Y, Ru Y, Song T, Guo L, Zhang X, Zhu J, Li C, Jin Z, Huang H, Tu Y, Xu M, Xu Y, Chen J, Wu D. Ding Y, et al. Ann Hematol. 2021 Nov;100(11):2773-2785. doi: 10.1007/s00277-021-04642-5. Epub 2021 Sep 4. Ann Hematol. 2021. PMID: 34480615 Free PMC article.

2

IL-39 promotes chronic graft-versus-host disease by increasing T and B Cell pathogenicity.

Lv K, Hu B, Xu M, Wan L, Jin Z, Xu M, Du Y, Ma K, Lv Q, Xu Y, Lei L, Gong H, Liu H, Wu D, Liu Y. Lv K, et al. Exp Hematol Oncol. 2022 Jun 2;11(1):34. doi: 10.1186/s40164-022-00286-x. Exp Hematol Oncol. 2022. PMID: 35655245 Free PMC article.

3

[The prognostic significance of pretransplantation evaluation of IPSS-R and WPSS in patients with myelodysplastic syndrome undergoing allogeneic hematopoietic stem cell transplantation].

Lu CQ, Hou C, Wang P, Zhang LW, Fan Y, Wu DP, Xu Y. Lu CQ, et al. Zhonghua Xue Ye Xue Za Zhi. 2022 Mar 14;43(3):247-254. doi: 10.3760/cma.j.issn.0253-2727.2022.03.011. Zhonghua Xue Ye Xue Za Zhi. 2022. PMID: 35405784 Free PMC article. Chinese.

4

Comparison of efficacy of eltrombopag combined with immunosuppression in the treatment of severe aplastic anemia and very severe aplastic anemia: real-world data and evidence.

Li X, Shangguan X, Wang H, Wang Q, Zhang Y, Han B, Liu R, Zhang F, Fu R, Lin Z, Miao M, Ma X, Lei M, Wu D, Liu L. Li X, et al. Ann Hematol. 2024 Sep;103(9):3483-3491. doi: 10.1007/s00277-024-05910-w. Epub 2024 Aug 1. Ann Hematol. 2024. PMID: 39088061

5

CD7-directed CAR T-cell therapy: a potential immunotherapy strategy for relapsed/refractory acute myeloid leukemia.

Cao X, Dai H, Cui Q, Li Z, Shen W, Pan J, Shen H, Ma Q, Li M, Chen S, Chen J, Zhu X, Meng H, Yang L, Wu D, Tang X. Cao X, et al. Exp Hematol Oncol. 2022 Sep 29;11(1):67. doi: 10.1186/s40164-022-00318-6. Exp Hematol Oncol. 2022. PMID: 36175988 Free PMC article.

6

[CAR T-cell bridging to allo-HSCT for relapsed/refractory B-cell acute lymphoblastic leukemia: the follow-up outcomes].

Yan M, Wu YJ, Chen F, Tang XW, Han Y, Qiu HY, Sun AN, Xue SL, Jin ZM, Wang Y, Miao M, Wu DP. Yan M, et al. Zhonghua Xue Ye Xue Za Zhi. 2020 Sep 14;41(9):710-715. doi: 10.3760/cma.j.issn.0253-2727.2020.09.002. Zhonghua Xue Ye Xue Za Zhi. 2020. PMID: 33113601 Free PMC article. Chinese.

7

[Allogeneic hematopoietic stem cell transplantation in acute leukemia patients with the SET-NUP214 fusion gene: Efficacy and survival analysis].

Xia J, Zhao Y, Chen F, Miao M, Qiu HY, Ma X, Tang XW, Wang Y, Wu XJ, Fu ZZ, Wu DP, Chen SN. Xia J, et al. Zhonghua Nei Ke Za Zhi. 2023 Apr 1;62(4):410-415. doi: 10.3760/cma.j.cn112138-20220411-00264. Zhonghua Nei Ke Za Zhi. 2023. PMID: 37032136 Chinese.

8

[Outcomes of allogeneic hematopoietic stem cell transplantation in patients with paroxysmal nocturnal hemoglobinuria compared to paroxysmal nocturnal hemoglobinuria-aplastic anemia syndrome].

Liu LM, Zhou HF, Wang QY, Qiu HY, Tang XW, Han Y, Fu CC, Jin ZM, Chen SN, Sun AN, Miao M, Wu DP. Liu LM, et al. Zhonghua Xue Ye Xue Za Zhi. 2019 Jun 14;40(6):472-476. doi: 10.3760/cma.j.issn.0253-2727.2019.06.005. Zhonghua Xue Ye Xue Za Zhi. 2019. PMID: 31340619 Free PMC article. Chinese.

9

[Clinical and prognostic values of TP53 mutation in patients with B-lineage acute lymphoblastic leukemia].

Du YY, Lyu KK, Xu MM, Yao WQ, Kang HZ, Han Y, Tang XW, Ma X, Wu XJ, He XF, Wu DP, Liu YJ. Du YY, et al. Zhonghua Xue Ye Xue Za Zhi. 2021 May 14;42(5):396-401. doi: 10.3760/cma.j.issn.0253-2727.2021.05.008. Zhonghua Xue Ye Xue Za Zhi. 2021. PMID: 34218582 Free PMC article. Chinese.

10

Liu L, Lei M, Fu R, Han B, Zhao X, Liu R, Zhang Y, Jiao W, Miao M, Zhang F, Zhang L, Wu D. Liu L, et al. J Hematol Oncol. 2022 Aug 12;15(1):105. doi: 10.1186/s13045-022-01324-1. J Hematol Oncol. 2022. PMID: 35962406 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Results by year